Seattle stem cell startup Curi Bio raises $6M

Seattle startup Curi Bio raised $6 million in a Series A funding round to further develop its human stem cell-based platforms for drug discovery. The company aims to provide drug developers with human-relevant cells, systems, and data to speed up the drug discovery process in the cardiac, skeletal muscle, and neuromuscular fields. The 6-year-old company currently has 29 employees.

READ THE STORY at GeekWire »